| Bioactivity | BRD4 Inhibitor-27 (compound 6) is a BRD4 inhibitor with IC50 of 9.6 and 11.3 μM for BRD4 BD1 and BRD4 BD2, respectively. BRD4 Inhibitor-27 has the potential to study cancer[1]. |
| Name | BRD4 Inhibitor-27 |
| CAS | 930039-92-2 |
| Formula | C16H13F3N6 |
| Molar Mass | 346.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kim JH, et al. Crystal structure of [1,2,4] triazolo[4,3- b ]pyridazine derivatives as BRD4 bromodomain inhibitors and structure–activity relationship study . Sci Rep 13, 10805 (2023). |
BRD4 Inhibitor-27
CAS: 930039-92-2 F: C16H13F3N6 W: 346.31
BRD4 Inhibitor-27 (compound 6) is a BRD4 inhibitor with IC50 of 9.6 and 11.3 μM forBRD4 BD1 andBRD4 BD2, respectively.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.